Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

New Science Ventures

New Science Ventures
VC INVESTOR TYPE
Active STATUS
8 PROFESSIONALS
101 INVESTMENTS
39 PORTFOLIO
29 EXITS
Description

New Science Ventures is a venture capital firm which focuses on investments in the life sciences (pharmaceuticals, biologics, medical devices, and diagnostics) and information technology (high-performance semiconductors, cellular infrastructure, sensor networks, enterprise software, and storage) sectors. The firm was founded in 2004 and is based in New York, New York.

Investor Status
Actively Seeking New Investments
Year Founded
2004
Primary Investor Type
Venture Capital
Primary Office
  • 299 Park Avenue
  • 41st Floor
  • New York, NY 10010
  • United States

+1 (212) 000-0000

New Science Ventures Investments (101)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NorthSea Therapeutics 08-Jan-2020 Early Stage VC 0000 Biotechnology Generating Revenue 000000000000 00000000000
0000 00000000 24-Jul-2019 00000 00000 000.00 Electronic Equipment and Instruments Generating Revenue
00000000 10-Jul-2019 00000 00000 000.00 Media and Information Services (B2B) Generating Revenue 00000 00000000 00.0
00000000 000000 00 15-May-2019 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 000000 000000
00000 (00 0000000) 19-Feb-2019 00000 00000 00.00 Storage (IT) Generating Revenue 00000 00000000 00.0
00000 00000 28-Nov-2018 00000 00000 000.00 Other Consumer Durables Generating Revenue
0000 00000000 14-Nov-2018 0000 00000 00.00 Electronic Equipment and Instruments Generating Revenue
00000 26-Sep-2018 00000 00000 0000 Electronics (B2C) Generating Revenue 000000000000 00000000000
Chromacure 29-May-2018 Early Stage VC 000.00 Biotechnology Startup 0000-000000 00000 00.0
Escalier Biosciences 04-Apr-2018 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 000000000000 00000000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore New Science Ventures’s full profile, request a free trial.

New Science Ventures Exits (29)

Company Name Exit Date Exit Type Exit Size Status Buyers
TherOx 18-Jun-2019 Merger/Acquisition Completed
00000000 12-Mar-2018 000000000000000000 0000 Completed
  • 00000000 00000000
00000000 0000000 01-Nov-2016 000 00 00000000 Completed
000000 00000000000 26-Aug-2016 000000000000000000 00.000 Completed
  • 00000000
00000000 000000000 02-Nov-2015 000000000000000000 00000 Completed
  • 0000000 0000000000
000000 000000 14-Oct-2015 000000000000000000 00.000 Completed
  • 00000
00000000000 01-Jun-2015 000000000000000000 000.00 Completed
  • 0000000 0000000000
000000 000000000 14-Jul-2014 000000000000000000 0000 Completed
  • 00000000
Lightwire 19-Mar-2012 Merger/Acquisition 00000 Completed
BioVex Group 04-Mar-2011 Merger/Acquisition 00000 Completed
To view this investor’s complete exits history, request access »

New Science Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore New Science Ventures‘s full profile, request access.

Request full access to PitchBook

New Science Ventures Team (12)

Name Title Deals Funds Boards Office Contact
Info
Lloyd Appel Chief Financial Officer New York, NY
Somasundaram Subramaniam Co-Founder & Managing Partner 00 0 00 New York, NY
Thomas Lavin Co-Founder & Partner 0 0 0 New York, NY
Jean-Pierre Bizet Ph.D Partner & Senior Advisor 0 0 0 New York, NY
John Cecil JD Partner & Senior Advisor New York, NY

3 Former Team Members

You’re viewing 5 of 12 team members. Get the full list »

New Science Ventures Co-Investors (88)

Name With Exits Lead Partner
Forbion 3 0 0
BioGeneration Ventures 0 0
Pierre Drion 0 0
Theodorus 0 0
Third Point Ventures 0 0 0
To view this investor’s complete co-investor history, request access »